Publications by authors named "Walter Cosolo"

Claim this Profile
A
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia.
Thomas J Kipps, Herbert Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo

Leuk Lymphomaยท September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis